ARCHIVES

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Ford To Resubmit Budget Slash Of $125 Million For NCI

January 3, 1975

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

White House Seek Elimination Of NCI’s Bypass Budget Authority In Legislation Renewing Cancer Act

April 9, 1982

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996